Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
     422  Antimetabolites
     423  Antibiotics
       4231  Mytomycin C
       4232  Chromomycin A3
       4233  Actinomycin D
       4234  Bleomycins
       4235  Anthracycline antibiotics
         D01275  Doxorubicin hydrochloride (JP17/USP)
         D01264  Daunorubicin hydrochloride (JP17/USP)
         D02214  Epirubicin hydrochloride (JP17/USP)
         D01911  Aclarubicin hydrochloride (JP17)
         D01747  Idarubicin hydrochloride (JP17/USP)
         D08386  Pirarubicin hydrochloride
         D07100  Amrubicin hydrochloride (JAN/USAN)
L01DB01
L01DB02
L01DB03
L01DB04
L01DB06
L01DB08
L01DB10
       4236  Neocarzinostatins
       4239  Others
     424  Plant extract preparations
     429  Miscellaneous
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: September 29, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version